Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 67 Records) |
| Query Trace: Myelodysplastic Syndromes and SF3B1[original query] |
|---|
| [Correlation between U2AF1 Gene Mutation Characteristics and Clinical Manifestations and Prognosis in Patients with Myelodysplastic Syndrome]. Zhongguo shi yan xue ye xue za zhi 2020 Dec 28 (6): 1977-1984. Zhao Wen-Shu, Zhang Yin-Tian, Jiang Qian-Li, Liu Qi-Fa, Dai M |
| Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2-mutated neoplasms. Leukemia 2020 12 35 (8): 2371-2381. Todisco Gabriele, Creignou Maria, Gallì Anna, Guglielmelli Paola, Rumi Elisa, Roncador Marco, Rizzo Ettore, Nannya Yasuhito, Pietra Daniela, Elena Chiara, Bono Elisa, Molteni Elisabetta, Rosti Vittorio, Catricalá Silvia, Sarchi Martina, Dimitriou Marios, Ungerstedt Johanna, Vannucchi Alessandro Maria, Hellström-Lindberg Eva, Ogawa Seishi, Cazzola Mario, Malcovati Lu |
| Real-world diagnostic testing patterns for assessment of ring sideroblasts and SF3B1 mutations in patients with newly diagnosed lower-risk myelodysplastic syndromes. International journal of laboratory hematology 2020 Nov . Patel Jay L, Abedi Mehrdad, Cogle Christopher R, Erba Harry P, Foucar Kathryn, Garcia-Manero Guillermo, Grinblatt David L, Komrokji Rami S, Kurtin Sandra E, Maciejewski Jaroslaw P, Pollyea Daniel A, Revicki Dennis A, Roboz Gail J, Savona Michael R, Scott Bart L, Sekeres Mikkael A, Steensma David P, Thompson Michael A, Dawn Flick Elizabeth, Kiselev Pavel, Louis Chrystal U, Nifenecker Melissa, Swern Arlene S, George Tracy |
| Utility of plasma cell-free DNA for de novo detection and quantification of clonal hematopoiesis. Haematologica 2021 9 107 (8): 1815-1826. Gutierrez-Rodrigues Fernanda, Beerman Isabel, Groarke Emma M, Patel Bhavisha A, Spitofsky Nina, Dillon Laura W, Raffo Diego Quinones, Hourigan Christopher S, Kajigaya Sachiko, Ferrucci Luigi, Young Neal |
| Myelodysplastic syndromes with 20q deletion: incidence, prognostic value and impact on response to azacitidine of ASXL1 chromosomal deletion and genetic mutations. British journal of haematology 2021 7 194 (4): 708-717. Martín Iván, Villamón Eva, Abellán Rosario, Calasanz Maria José, Irigoyen Aroa, Sanz Guillermo, Such Esperanza, Mora Elvira, Gutiérrez Míriam, Collado Rosa, García-Serra Rocío, Vara Míriam, Blanco Mª Laura, Oiartzabal Itziar, Álvarez Sara, Bernal Teresa, Granada Isabel, Xicoy Blanca, Jerez Andrés, Calabuig Marisa, Diez Rosana, Gil Ángela, Díez-Campelo María, Solano Carlos, Tormo Mar, |
| The utility of a myeloid mutation panel for the diagnosis of myelodysplastic syndrome and myelodysplastic/myeloproliferative neoplasm. International journal of laboratory hematology 2021 7 43 (6): 1501-1509. Ibrar Warda, Zhang Weiwei, Cox Jesse Lee, Cushman-Vokoun Allison, Fu Kai, Greiner Timothy C, Yuan |
| Only SF3B1 mutation involving K700E independently predicts overall survival in myelodysplastic syndromes. Cancer 2021 Jun . Kanagal-Shamanna Rashmi, Montalban-Bravo Guillermo, Sasaki Koji, Darbaniyan Faezeh, Jabbour Elias, Bueso-Ramos Carlos, Wei Yue, Chien Kelly, Kadia Tapan, Ravandi Farhad, Borthakur Gautam, Soltysiak Kelly A, Routbort Mark, Patel Keyur, Pierce Sherry, Medeiros L Jeffrey, Kantarjian Hagop M, Garcia-Manero Guiller |
| Letter to the Editor regarding the article "Prognostic significance of SF3B1 mutations in patients with myelodysplastic syndromes: A meta-analysis". Critical reviews in oncology/hematology 2021 5 162 103295. Yang Tingfang, Wang Li, Zhang Yo |
| Distinct bone marrow immunophenotypic features define the splicing factor 3B subunit 1 (SF3B1)-mutant myelodysplastic syndromes subtype. British journal of haematology 2021 3 193 (4): 798-803. Duetz Carolien, Westers Theresia M, In 't Hout Florentien E M, Cremers Eline M P, Alhan Canan, Venniker-Punt Bianca, Visser-Wisselaar Heleen A, Chitu Dana A, de Graaf Aniek O, Smit Linda, Jansen Joop H, van de Loosdrecht Arjan |
| Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes. Cancer medicine 2021 Feb . Yan Xuefen, Wang Lu, Jiang Lingxu, Luo Yingwan, Lin Peipei, Yang Wenli, Ren Yanling, Ma Liya, Zhou Xinping, Mei Chen, Ye Li, Xu Gaixiang, Xu Weilai, Yang Haiyang, Lu Chenxi, Jin Jie, Tong Hongy |
| [Characteristics and Clinical Significance of Gene Mutation in Patients with Myelodysplastic Syndrome]. Zhongguo shi yan xue ye xue za zhi 2021 12 29 (6): 1864-1868. Zhao Fang, Wang Kai-Li, Qin Yu-Ting, Nilupar Tuerxun, Patiguli Abulizi, Jiang Ming, Hao Jian-Pi |
| Have we reached a molecular era in myelodysplastic syndromes? Hematology. American Society of Hematology. Education Program 2021 12 2021 (1): 418-427. Voso Maria Teresa, Gurnari Carme |
| Impact of mutational variant allele frequency on prognosis in myelodysplastic syndromes. American journal of cancer research 2020 10 (12): 4476-4487. Jiang Lingxu, Wang Lu, Shen Chuying, Zhu Shuanghong, Lang Wei, Luo Yingwan, Zhang Hua, Yang Wenli, Han Yueyuan, Ma Liya, Ren Yanling, Zhou Xinping, Mei Chen, Ye Li, Xu Weilai, Yang Haiyang, Lu Chenxi, Jin Jie, Tong Hongy |
| High erythroferrone expression in CD71 erythroid progenitors predicts superior survival in myelodysplastic syndromes. British journal of haematology 2021 1 192 (5): 879-891. Riabov Vladimir, Mossner Maximilian, Stöhr Alexandra, Jann Johann-Christoph, Streuer Alexander, Schmitt Nanni, Knaflic Antje, Nowak Verena, Weimer Nadine, Obländer Julia, Palme Iris, Schumann Christiane, Baldus Claudia D, Schulze Torsten J, Wuchter Patrick, Röhl Henning, Jawhar Ahmed, Weiss Christel, Boch Tobias, Metzgeroth Georgia, Neumann Martin, Hofmann Wolf-Karsten, Nolte Florian, Nowak Dani |
| ASXL1 mutations with serum EPO levels predict poor response to darbepoetin alfa in lower-risk MDS: W-JHS MDS01 trial. International journal of hematology 2022 7 116 (5): 659-668. Morita Yasuyoshi, Nannya Yasuhito, Ichikawa Motoshi, Hanamoto Hitoshi, Shibayama Hirohiko, Maeda Yoshinobu, Hata Tomoko, Miyamoto Toshihiro, Kawabata Hiroshi, Takeuchi Kazuto, Tanaka Hiroko, Kishimoto Junji, Miyano Satoru, Matsumura Itaru, Ogawa Seishi, Akashi Koichi, Kanakura Yuzuru, Mitani Kinu |
| Genetic mutations associated with blood count abnormalities in myeloid neoplasms. Hematology (Amsterdam, Netherlands) 2022 6 27 (1): 765-771. Polprasert Chantana, Kongkiatkamon Sunisa, Niparuck Pimjai, Rattanathammethee Thanawat, Wudhikarn Kitsada, Chuncharunee Suporn, Kobbuaklee Sirorat, Suksusut Amornchai, Lanamtieng Theerin, Lawasut Panisinee, Asawapanumas Thiti, Bunworasate Udomsak, Rojnuckarin Ponlap |
| Splicing factor 3B subunit 1 (SF3B1) mutation in the context of therapy-related myelodysplastic syndromes. British journal of haematology 2022 6 198 (4): 713-720. Volpe Virginia O, Al Ali Najla, Chan Onyee, Padron Eric, Sallman David A, Kuykendall Andrew, Sweet Kendra, Lancet Jeffrey E, Komrokji Rami |
| Comprehensive analysis of genetic factors predicting overall survival in Myelodysplastic syndromes. Scientific reports 2022 4 12 (1): 5925. Maurya Nehakumari, Mohanty Purvi, Dhangar Somprakash, Panchal Purvi, Jijina Farah, Mathan S Leo Prince, Shanmukhaiah Chandrakala, Madkaikar Manisha, Vundinti Babu R |
| Low-Risk Myelodysplastic Syndrome Revisited: Morphological, Autoimmune, and Molecular Features as Predictors of Outcome in a Single Center Experience. Frontiers in oncology 2022 4 12 795955. Fattizzo Bruno, Levati Giorgia Virginia, Giannotta Juri Alessandro, Cassanello Giulio, Cro Lilla Marcella, Zaninoni Anna, Barbieri Marzia, Croci Giorgio Alberto, Revelli Nicoletta, Barcellini Wil |
| New genetic variants of TET2 and ASXL1 identified by next generation sequencing and pyrosequencing in a patient with MDS-RS-MLD and secondary acute myeloid leukemia. Central-European journal of immunology 2022 2 46 (4): 524-530. Adamska Monika Ma?gorzata, Kowal-Wi?niewska Ewelina, Kiwerska Katarzyna, Ustaszewski Adam, Czerwi?ska-Rybak Joanna, Kandu?a Zuzanna, Wojtaszewska Marzena, Bara?ska Marta, Pruchniewski ?ukasz, Lewandowski Krzysztof, Jarmu?-Szymczak Ma?gorzata, Gil Lid |
| Molecular and cytogenetic characterization of myelodysplastic syndromes in cell-free DNA. Blood advances 2022 2 6 (10): 3178-3188. Garcia-Gisbert Nieves, Garcia-Ávila Sara, Merchán Brayan, Salido Marta, Fernández-Rodríguez Concepción, Gibert Joan, Fernández-Ibarrondo Lierni, Camacho Laura, Lafuente Marta, Longarón Raquel, Espinet Blanca, Vélez Patricia, Pujol Ramon M, Andrade-Campos Marcio, Arenillas Leonor, Salar Antonio, Calvo Xavier, Besses Carles, Bellosillo Beatr |
| Therapeutic Outcomes and Prognostic Impact of Gene Mutations Including TP53 and SF3B1 in Patients with Del(5q) Myelodysplastic Syndromes (MDS). Clinical lymphoma, myeloma & leukemia 2022 2 22 (7): e467-e476. Chan Onyee, Ali Najla Al, Sallman David, Padron Eric, Lancet Jeffrey, Komrokji Ra |
| Distinct genetic landscapes and their clinical implications in younger and older patients with myelodysplastic syndromes. Hematological oncology 2022 11 . Lee Wan-Hsuan, Lin Chien-Chin, Wang Yu-Hung, Yao Chi-Yuan, Kuo Yuan-Yeh, Tseng Mei-Hsuan, Peng Yen-Ling, Hsu Cheng-An, Sun Hsun-I, Chuang Yi-Kuang, Hsu Chia-Lang, Tien Feng-Ming, Tsai Cheng-Hong, Chou Wen-Chien, Hou Hsin-An, Tien Hwei-Fa |
| Phase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromes. Leukemia research 2023 9 134 107390. Tamanna Haque, Felix López Cadenas, Blanca Xicoy, Ana Alfonso-Pierola, Uwe Platzbecker, Irit Avivi, Andrew M Brunner, Jöerg Chromik, Daniel Morillo, Manish R Patel, Jose Falantes, Heather A Leitch, Ulrich Germing, Meir Preis, Laurie Lenox, Josh Lauring, Regina J Brown, Anna Kalota, Jaydeep Mehta, Friederike Pastore, Junchen Gu, Pankaj Mistry, David Valcárc |
| Impact of single versus multiple spliceosome mutations on myelodysplastic syndrome. Journal of clinical and experimental hematopathology : JCEH 2023 9 63 (3): 173-176. Pakasticali Nagehan, Mirza Sabbir, Jinming Song, Hussaini Mohamm |
| The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblasts. Research square 2023 4 . In Young Choi, Jonathan Ling, Jian Zhang, Eric Helmenstine, Wencke Walter, Riley Bergman, Céline Philippe, James Manley, Kevin Rouault-Pierre, Bing Li, Daniel Wiseman, Madhu Ouseph, Elsa Bernard, Xiao Li, Torsten Haferlach, Salman Fazal, Tania Jain, Christopher Gocke, Amy DeZern, W Brian Dalt |
| Identification of novel myelodysplastic syndromes prognostic subgroups by integration of inflammation, cell-type composition, and immune signatures in the bone marrow. eLife 2024 9 13 . Sila Gerlevik, Nogayhan Seymen, Shan Hama, Warisha Mumtaz, I Richard Thompson, Seyed R Jalili, Deniz E Kaya, Alfredo Iacoangeli, Andrea Pellagatti, Jacqueline Boultwood, Giorgio Napolitani, Ghulam J Mufti, Mohammad M Kari |
| Analyzing Differences in Hematological and Immunological Characteristics Related to Common Gene Mutations in Myelodysplastic Syndromes. Discovery medicine 2024 6 36 (185): 1289-1297. Jianing Yu, Xiaohuan Peng, Rui Wang, Jun Bai, Yanhong Li, Liansheng Zhang, Lijuan |
| Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes. Blood 2024 4 . Maria Sirenko, Elsa Bernard, Maria Creignou, Dylan Domenico, Andrea Farina, Juan Esteban Arango Ossa, Olivier Kosmider, Robert P Hasserjian, Martin Jädersten, Ulrich Germing, Guillermo F Sanz, Arjan A van de Loosdrecht, Carmelo Gurnari, Matilde Y Follo, Felicitas R Thol, Lurdes Zamora, Ronald Feitosa Pinheiro, Andrea Pellagatti, Harold Kunal Elias, Detlef Thomas Haase, Birgitta Sander, Elisa Orna, Katharina Zoldan, Lea Naomi Eder, Wolfgang R Sperr, Renate Thalhammer, Christina Ganster, Lionel Adès, Magnus Tobiasson, Laura Palomo, Matteo Giovanni Della Porta, Kety H Huberman, Pierre Fenaux, Monika Belickova, Michael R Savona, Virginia Klimek, Fabio P S Santos, Jacqueline Boultwood, Ioannis Kotsianidis, Valeria Santini, Francesc Sole, Uwe Platzbecker, Michael Heuser, Peter Valent, Carlo Finelli, Maria Teresa Voso, Lee Yung Shih, Seishi Ogawa, Michaela Fontenay, Joop H Jansen, José Cervera, Benjamin L Ebert, Rafael Bejar, Peter L Greenberg, Norbert Gattermann, Luca Malcovati, Mario Cazzola, David B Beck, Eva S Hellstrom-Lindberg, Elli Papaemmanu |
| Validation and comparison of 5th edition World Health Organization classification (WHO 2022) and International Consensus Classification proposals for MDS-SFB31. British journal of haematology 2024 4 . Linlin Liu, Bing Li, Zefeng Xu, Tiejun Qin, Yujiao Jia, Shiqiang Qu, Yudi Zhang, Junying Wu, Wenyu Cai, Lijuan Pan, Qingyan Gao, Meng Jiao, Zhijian Xi |
- Page last reviewed:Feb 1, 2024
- Content source: